COVID-19 vaccine uptake and intention during pregnancy in Canada

PDF

"The objective of this research was to investigate COVID-19 vaccine uptake and intent among pregnant people in Canada, and determine associated factors." - COVID-19 vaccine uptake and intention during pregnancy in Canada

Additional Authors: Samantha B. Meyer, Julie A. Bettinger, S. Michelle Driedger, Joan Robinson, Manish Sadarangani, Sarah E. Wilson, Karen Benzies, Samuel Lemaire-Paquette, Arnaud Gagneur, Shannon E. MacDonald

Related Resources

Bookmark

Evidence

PDF

Author: Laura Reifferscheid, Emmanuel Marfo, Ali Assi, Ève Dubé, Noni MacDonald Published: 2022 Region: National Audience: Health Care Professional Product Type: Article Language: English Population: Pregnant and Breastfeeding People

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.

COVID-19 vaccine uptake and intention during pregnancy in Canada

Evidence

Category

0 Comments

Make the most of the CANVax community. Join today!

The Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)

COVID-19 vaccine uptake and intention during pregnancy in Canada

Evidence

Category

0 Comments

COVID-19 Vaccine for Kids Under 5

Summary of National Advisory Committee on Immunization (NACI) Statement of June 29, 2022 : Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada

Summary of National Advisory Committee on Immunization (NACI) Statement of July 14, 2022 : Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age

Communicating About Vaccines – COVID-19 & More

Moving to Acceptance: Strategies to address concerns about vaccines

Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022

Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022

National Advisory Committee on Immunization (NACI) : Interim guidance on planning considerations for a fall 2022 COVID-19 vaccine booster program in Canada

An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 months to 5 years of age

Create an account

Create an account

Resource Rating Breakdown

The Canadian Vaccination Evidence Resource and Exchange Centre (CANVax)